Promoter collection, Human MYB promoter
Alternative name | U2812-7 |
---|---|
Clone info. | PCR amplified human MYB promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 135179905 to 135181339(NC_000006.12 ); relatively -1410 to +25, where +1 corresponds to 1 nt of NM_001130173.1. |
Comment | PCR cloning, forward primer: TCTTGAAACCTCGCATGCTT; reverse primer: GAGGAGGAGGAAACAGGTTGA. Entire sequence of promoter region has not been confirmed. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human v-myb myeloblastosis viral oncogene homolog genomic DNA |
Depositor|Developer | DNA Bank, | |
Remarks, protocol and/or map (pdf) | RDB07480.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07480 | pGL4-phMYB (c-myb) | DNA solution |
Materials & Methods section:
The pGL4-phMYB (c-myb) was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07480). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07480_A5A6.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pGL4-4174F Sequence file: RDB07480_A5A6a.seq |
---|
>07480_07480_A5A6_pGL4-4174F_A01_01.ab1 1 TTCTGTTTCC AGGACATTTC TCTGGCCTAA CTGGCCGGTA CCTGAGCTCG CTAGCCTCGA 61 GGATTCTTGA AACCTCGCAT GCTTCACCGT TTAATAAAAT TATGACTCAT TTTAGTAAGA 121 ACATGCTTTT TTAGTAAGAA AAAATGCTTT CTGAGCTAAG TTTGAACTGC TGGGGCACAT 181 GGGACACCCA CAAACCCAGT CAGCAGAAGT CTCAAACTCC TAAAAGATTA AAGGAAAAAT 241 ACATTAGTGT GTACAGAGAA TGAAAAAAAA ATCCCCAATG GTTCTAATCT ATAAACGGAA 301 GTAAAACTAA AACTCCCCTA AAATCCCCCC AGTCATCAAT CCTTATAAAT TCAGCACTTA 361 TCTTCTTCCT TTACTTCTGG AGACCCTCAT TAAACAACAC GAAAGCCTTT GCTGACTTTT 421 ATCTCGTAAA ATAGAGCCCT CAAATGACAC TAAGCAGGGA TACCGACCTC CAAAATCACA 481 AACTGTTTTA CTTCTAAAAC CATGCATGCA AACGTGGGGT TTCCTGAGTT CTGCTAGGGG 541 CGGGCTGTCT GGACCCCCGT GTATTTTTTT TTTTTTTTTT TTTTTTTTTT TTTGCAGGTG 601 TGCAATCCAG GGTGCGCGCT CTGTGCAGGG AGGGGAGCAG AAGTGTGCGG TGGGCACCGC 661 CTGGGCCGGG CGGGGCGGGG TGGGTGGGGC CCGGGTGTGT GCTGGGGTGA GAGTGAAGGA 721 CATGTGACAA TACGACGGTG GCGGCTGCAG GATCCGGGAG GGGAGTGAAA GCTCCGCTGG 781 GGCGCTCCAT TAGTGAGCGG TGATGGTTGC CGCCCACTTG TATTGAAGCG TCCTTTGTCA 841 CTAACAAGTT AATTAGAGAT GTTATTTATT TAAGAAGAAG GAAAAAAAAA CCCTAGCCAA 901 ACAGCCTATG AATACATATG CTCACATCCC CCTACTCCTC CAACTCCCTA ATTTTCCCCC 961 GTCTCCAGAG GGGCACAGTT GTAAACCTTG TACGAAAAAT TCCAATTCTT TCTTGGGTGC 1021 GGGGAATTTT CCCCCCCCAC CGGCTTTGCC GCCCCCCCGC CGAAAGTGGA GTTGGGGGAG 1081 CTGGGAAGGG AGCTCTCTTG GGTCCCCGCT GGTCTCCGGG AGGCACCGCG GGGAAGCCGG 1141 GGGCGGACGC GGGGGGTGGC GGGTCAGGCC TAGGGAGGGT AGTATGGATG GTCTCGTCCT 1201 CGGGGAACCT ATGTGGGGGG CCGGCACGTC GGGCGGT // |
Primer: pGL4-136R Sequence file: RDB07480_A5A6b.seq |
>07480_07480_A5A6_pGL4-136R_B01_04.ab1 1 GCCATTCCAA GTGTTTTGGC ATCTTCCATG GTGGCTTTAC CAACAGTACC GGATTGCCAA 61 GCTTGGCCGC CGAGGCCAGA TCTTGATGAG GAGGAGGAAA CAGGTTGATA TTAAAGTGTA 121 AACTCTGTAA ACAGAGATGC CATCAAACAA AGAGCTTTGG ACACTCCCCC TCCCGCCAAA 181 TCTGGCGCCC CTGCAGTGCG CACGCGCCCT GCCCGCCGCC TCCGCGGTCG CCCTGGCTGC 241 CGCCCGCGGG GCTGCCGGGC TGGCCGGGTC GCCGCTCCCA TTCGGCGCTC GCGCCGCCGC 301 GGTGCGCCTA GCGCGCCGCG AGGCCCGGGA GGCGCGCGGG CAGGGAGCCC GGGGCCAGGG 361 AGGGGTGGCC GGGGGCCGCG ACGGCGCCTT TTCCTGAGCA AACCCCGCTC CCGGGTCGCG 421 GCGGCGCCGA CCCGCGCCCA GTCCCGCCGC CTCCCCTCCT CCCTGGCTGC CGCACCGCGG 481 TCGCCCGGCT CCGCGTGCTC CCGGGCAGCG GGACCAGAGC TCCTCCAGCT CCCACTCACT 541 GTCGCGGGGG CGGCAAGCGG TGGGGGGAAA TTCCCGCACA GAAGATTGGA TTTTCGTCAA 601 GGTTTACAAC TGTGCCCTCT GGAGACGGGG AAATTAGGAG TTGGAGGAGT AGGGGATGTG 661 AGCATATGTA TTCATAGGCT GTTTGGCTAG GGTTTTTTTT CCTTCTTCTT AAATAAATAA 721 CATCTCTAAT TTAACTTGTT AGTGACAAAG GACGCTTCAA TACAAGTGGG CGGCAACCAT 781 CACCGCTCAC TAATGGAGCG CCCCAGCGGA GCTTTCACTC CCCTCCCGGA TCCCTGCAGC 841 CGCCACCGTC GTATTGTCAC ATGTCCTTTC ACTCTCACCC CAGCACACAC CCGGGCCCCA 901 CCCAACCCCG CCCCGCCCGG CCCAAGGCGG TGCCCCACCG CACACCCTCT GCTCCCCCTC 961 CCTGCACAGA GCGCGGCACC CCTGGAATTT GCCACACCCT GGCAAAAAAA AAAAAAAAAA 1021 AAAAAAAAAA TACCACGGGG GGTTCCAGAA CAGCCCCGCC CCCTAACCAG AACCTCAGGA 1081 AACCCCCCAC GGTTTGGCCC ATGGCCATGG GTTTTTAGAG AAGTAAAAAA CCGAGTTTTG 1141 GTGAATTTTT GGGAAGGTTC CCGGGTTAAT TCCCCTCGTG TCCTTTAATA AGGGGGGTCT 1201 CAC // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content